As shown in Fig. 7a–c, the levels of GLT-1+, SYN211+, and MJFR14+ EVs in the PD group were all significantly higher than those in the HC group, while there was no significant difference between the MSA and HC groups. This evidence concerns the gene SLC1A2 and Parkinson disease.